Polares Medical

— Reshaping treatment for Functional Mitral Regurgitation (FMR) Transcatheter Leaflet Restoration (TLR) system is engineered to work in harmony with the native leaflets and the Mitral Valve apparatus to restore the function of the valve while preserving natural blood flow in patients with FMR.

Health and bio

Latest funding

$50M Series B+ · March 3, 2026

Led by Decheng Capital · Source: fundraisingfox.com

Total raised: $115M across 3 sourced rounds

All 3 rounds ↓

Website: polaresmedical.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Health Care, Medical, Medical Device.

Stage: Series B+.

Based in: Palo Alto, United States.

Founded: 2017.

Total raised: $115M in 3 sourced rounds.

Last round: Mar 3, 2026 · 257 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Sep 29, 2026.

Signals

Website registeredJun 20, 2017 (9 years old)

TIMELINE · MONEY RAISED

Polares Medical | 392 days from website to first raise on record

Raised $115M in 3 sourced rounds·1 signal before the first raise

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

Funding rounds

Date	Round	Amount	Lead	Source
Mar 3, 2026	Series B+	$50M	DDecheng Capital	fundraisingfox.com
Jun 25, 2020	Series B+	$40M	—	startupticker.ch
Jul 17, 2018	Series A	$25M	DDecheng Capital	b3cnewswire.com

Timeline

June 20, 2017
Website created

Founders and team

JE
Jacques Essinger Co-founder, CEO, Chairman

LinkedIn · source: polaresmedical.com
AK
Alex Khairkhahan Co-founder, COO, CTO

source: polaresmedical.com
MC
Min Cui Founder and Managing Director

source: polaresmedical.com
SK
Stephen Kao Vice President of R&D

Investors

Companies like Polares Medical

HHVR Cardio$11.1M Series B+ · Jan 2023
VVersa VascularSeries B+ · Aug 2026
RRevamp MedicalSeries A · May 2023
CClaris Bio$118M Series B+ · Jul 2026
AAutoimmunity BioSolutionsSeed · May 2026
GGesynta PharmaSeries B+ · Jul 2025

Other companies backed by Decheng Capital

PPhrontline Biopharma$40M Series A · Nov 2026
YYolTech Therapeutics$45M Series B+ · Sep 2025
VVintaBio$64M · Apr 2023
MMirvie$60M Series B+ · May 2022
AAnHeart Therapeutics$61M Series B+ · Dec 2021
HHaoxinqingSeries B+ · Sep 2026

Decheng Capital portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/polares-medical (get a free API key).